Advertisement

Topics

Agile Therapeutics resubmits new drug application for Twirla contraceptive patch to FDA

04:52 EDT 17 May 2019 | Proactive Investors

The New Jersey company originally submitted its application for FDA approval in December 2017, but the regulator requested more data

Original Article: Agile Therapeutics resubmits new drug application for Twirla contraceptive patch to FDA

NEXT ARTICLE

More From BioPortfolio on "Agile Therapeutics resubmits new drug application for Twirla contraceptive patch to FDA"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...